{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:52:28Z","timestamp":1760550748571,"version":"3.37.3"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2014R1A5A2010008"],"award-info":[{"award-number":["2014R1A5A2010008"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0209998","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T18:50:57Z","timestamp":1547751057000},"page":"e0209998","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16)"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6115-2804","authenticated-orcid":true,"given":"Sang Jun","family":"Byun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan Ho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ah Ram","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Mun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7918-1072","authenticated-orcid":true,"given":"Jin Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.eururo.2013.10.001","article-title":"International variations in bladder cancer incidence and mortality","volume":"66","author":"S Chavan","year":"2014","journal-title":"Eur Urol"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4111\/kju.2015.56.6.422","article-title":"Incidence of kidney, bladder, and prostate cancers in Korea: An update","volume":"56","author":"W Song","year":"2015","journal-title":"Korean J Urol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","article-title":"Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines","volume":"59","author":"A Stenzl","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2011.11.010","article-title":"Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience","volume":"61","author":"JA Efstathiou","year":"2012","journal-title":"Eur Urol"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"HB Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"JP Stein","year":"2001","journal-title":"J Clin Oncol"},{"issue":"9373","key":"ref7","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(03)13580-5","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.eururo.2006.06.014","article-title":"Perioperative complications of radical cystectomy in a contemporary series","volume":"51","author":"V Novotny","year":"2007","journal-title":"Eur Urol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.urology.2006.01.051","article-title":"Complications after radical cystectomy: analysis of population-based data","volume":"68","author":"BR Konety","year":"2006","journal-title":"Urology"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.urolonc.2016.03.011","article-title":"Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer","volume":"34","author":"DR McHaffie","year":"2016","journal-title":"Urol Oncol"},{"issue":"6 Pt 1","key":"ref11","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium","volume":"176","author":"SF Shariat","year":"2006","journal-title":"J Urol"},{"issue":"34","key":"ref12","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1200\/JCO.2014.57.5548","article-title":"Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233","volume":"32","author":"RH Mak","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2014.02.038","article-title":"Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review","volume":"66","author":"G Ploussard","year":"2014","journal-title":"Eur Urol"},{"issue":"16","key":"ref14","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"ND James","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1200\/JCO.2010.31.5721","article-title":"Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer","volume":"29","author":"A Choudhury","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1016\/j.ijrobp.2011.05.051","article-title":"Whole-pelvis or bladder-only chemoradiation for lymph node-negative invasive bladder cancer: single-institution experience","volume":"82","author":"MA Tunio","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijrobp.2009.10.038","article-title":"Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97\u2013015)","volume":"79","author":"JL Lagrange","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.urology.2012.07.045","article-title":"Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy","volume":"80","author":"A Zapatero","year":"2012","journal-title":"Urology"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.urology.2008.03.017","article-title":"Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis","volume":"72","author":"F Koga","year":"2008","journal-title":"Urology"},{"issue":"14","key":"ref20","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2002.11.027","article-title":"Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results","volume":"20","author":"C Rodel","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1442-2042.2009.02425.x","article-title":"Laparoscopic versus open radical cystectomy for the management of bladder cancer: mid-term oncological outcome","volume":"17","author":"US Ha","year":"2010","journal-title":"Int J Urol"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1442-2042.2012.02974.x","article-title":"Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review","volume":"19","author":"F Koga","year":"2012","journal-title":"Int J Urol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0360-3016(03)00718-1","article-title":"RTOG 97\u201306: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy","volume":"57","author":"MP Hagan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/107327480000700403","article-title":"Bladder-sparing treatment of invasive bladder cancer","volume":"7","author":"I Rivera","year":"2000","journal-title":"Cancer Control"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ijrobp.2015.12.379","article-title":"Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (<\/ = 70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer","volume":"94","author":"S Hafeez","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2015.09.010","article-title":"Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study","volume":"94","author":"V Murthy","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.urology.2013.09.058","article-title":"Intravesical lipiodol injection technique for image-guided radiation therapy for bladder cancer","volume":"83","author":"AS Baumgarten","year":"2014","journal-title":"Urology"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijrobp.2009.08.019","article-title":"Behavior of lipiodol markers during image guided radiotherapy of bladder cancer","volume":"77","author":"X Chai","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6024","key":"ref29","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"RD Schreiber","year":"2011","journal-title":"Science (New York, NY)"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"WH Fridman","year":"2017","journal-title":"Nature reviews Clinical oncology"},{"key":"ref31","article-title":"Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways","author":"M Rouanne","year":"2018","journal-title":"World journal of urology"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3857\/roj.2015.33.4.294","article-title":"Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer","volume":"33","author":"SJ Byun","year":"2015","journal-title":"Radiat Oncol J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0209998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:00:28Z","timestamp":1588964428000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0209998"}},"subtitle":[],"editor":[{"given":"Mitesh J.","family":"Borad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0209998","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,1,17]]}}}